Keyword: GlaxoSmithKline (GSK)

News

Glaxo’s Shingles Vaccine Wins Chinese Approval

29.05.2019 - China’s drug regulatory authority, National Medical Product Administration (NMPA), has approved GlaxoSmithKline’s new vaccine for herpes zoster (shingles) in adults 50 years old or...

News

GlaxoSmithKline to Buy Tesaro for $5.1 Billion

07.12.2018 - UK drugmaker GlaxoSmithKline (GSK) has entered into a definitive agreement to acquire Tesaro, a commercial-stage biopharmaceutical company based in Waltham, Massachusetts, USA, for...

Markets & Companies

Opportunities for Western CDMOs in China

29.11.2018 - As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...

Logistics & Supply Chain

Achema 2018: Source for Taillored Logistics Solutions

26.04.2018 - For the first time Achema 2018 invites to a special exhibition zone in Hall 1.1 presenting a Logistics Hotspot for the chemical and pharmaceutical industry. Sonja Andres of...

Logistics & Supply Chain

Achema 2018: Logistics Hotspot Comes to Stay

26.04.2018 - Aren’t there quite some logistics trade shows already? Yes, there are! But there you have to look very closely to find specialists catering to the chemical and pharmaceutical...

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...

News

GSK said Eyeing Bid for Vectura

18.01.2018 - GlaxoSmithKline (GSK), the UK’s largest drugmaker in terms of sales, is rumored to be preparing a bid for compatriot Vectura, an inhaled airways disease-focused player. The two...

News

UK Watchdog Finds Concordia Guilty of Market Abuse

30.11.2017 - In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...